Risk-adapted therapy for young children with medulloblastoma (SJYC07): results and molecular analysis from a multicenter phase II trial

BACKGROUND: Young children with medulloblastoma have inferior survival to older children. While the principal difference is due to radiation-sparing therapy, radiation is not an absolute requisite for survival of all. We aimed to estimate the event-free survival of young medulloblastoma patients wit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lancet Oncol
Main Authors: Robinson, Giles W., Rudneva, Vasilisa A., Buchhalter, Ivo, Billups, Catherine A., Waszak, Sebastian M., Smith, Kyle S., Bowers, Daniel C., Bendel, Anne, Fisher, Paul G., Partap, Sonia, Crawford, John R., Hassall, Tim, Indelicato, Daniel J., Boop, Frederick, Klimo, Paul, Sabin, Noah D., Patay, Zoltan, Merchant, Thomas E., Stewart, Clinton F., Orr, Brent A., Korbel, Jan O., Jones, David T.W., Sharma, Tanvi, Lichter, Peter, Kool, Marcel, Korshunov, Andrey, Pfister, Stefan M., Gilbertson, Richard J., Sanders, Robert P., Onar-Thomas, Arzu, Ellison, David W., Gajjar, Amar, Northcott, Paul A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6078206/
https://ncbi.nlm.nih.gov/pubmed/29778738
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(18)30204-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados